Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AquADEKs is an antioxidant-enriched multivitamin supplement specifically formulated for patients with cystic fibrosis (CF) and other malabsorptive conditions. It utilizes a specialized delivery technology to provide fat-soluble vitamins (A, D, E, and K) in a water-miscible form, ensuring better absorption in individuals with pancreatic insufficiency. The formulation is further enhanced with a potent antioxidant blend, including coenzyme Q10 (CoQ10), beta-carotene, mixed tocopherols, and carotenoids such as lutein, lycopene, and zeaxanthin, along with essential minerals like zinc and selenium. AquADEKs is designed to address the chronic oxidant/antioxidant imbalance and systemic inflammation associated with CF, aiming to improve nutritional status and mitigate lung damage caused by oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AquADEKs.